The UCLA Breast Center was first established in 1992 under the directorship of Dr. Susan Love. The mission of the UCLA Breast Center is to bring the most comprehensive and compassionate care to our patients and to develop future medicine to end the suffering of women with breast cancer.
From the beginning, the UCLA Breast Center established a multidisciplinary clinical practice to deliver one-stop care to our patients. Four interdisciplinary programs were developed, including a daily
Diagnostic Program and three weekly programs: The
Multidisciplinary, the
Follow-up and the
High Risk Programs. Patients with increased risk of having breast cancer, with various breast problems, with breast cancer, and those who have completed their breast cancer treatment can all find the particular program to meet their special needs.
In 1996, the
Revlon Foundation made a generous gift to the UCLA Breast Center and the Revlon/UCLA Breast Center was born. The following year, Dr. Helena Chang was recruited to lead the
Revlon/UCLA Breast Center. The Center has an architecturally unique appearance, with calmness, beauty and functional design that distinguishes the Center. The attention to patients’ emotional and clinical needs truly reflects our commitment and inspiration by providing the best and the most compassionate care to women with breast problems. Each year, the Center provides exceptional care, with more than 4,000 visits by women who are seeking diagnosis, treatment and advice.
To meet the challenge of developing tomorrow’s medicine in breast cancer detection, treatment and prevention, Dr. Chang established a laboratory dedicated to the study of molecular signatures of breast cancer. The laboratory was established in 1999 with a generous gift from the
Gonda/Goldschmied Foundation. Samples of consented patients’ blood, urine, nipple fluid and tissue have been systematically collected to develop clinically useful laboratory tests to guide the early detection and treatment of breast cancer.
To fulfill the goal of developing successful translational research that brings laboratory findings to the bedside, Dr. Chang established a Clinical Trials Unit for Breast Cancer in 2002. The mission of Clinical Trials Unit is to conduct high quality studies with strong scientific merits and real clinical value. The Clinical Trials Unit also protects the individual rights and confidentiality of each participant.
Through our vision, mission and dedication, the Revlon/UCLA Breast Center leads the field of total breast care. We are committed to serve our patients, our community and women from all corners of the world.
